# Christopher Grant

> Christopher Grant is a Series B investor at Kaiser Permanente Ventures backing Health Care. See 5 investments, check sizes, portfolio and contact details…

- Type: Angel Investor
- Fund: [Kaiser Permanente Ventures](https://shizune.co/investors/profile/kaiser-permanente-ventures)
- Location: Pleasanton, United States
- Total investments: 5
- Last investment: Jul 2016
- Lead investor: 0%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/chris-grant-2a791264
- X (Twitter): https://x.com/cmgrant

Christopher Grant is a Series B investor at Kaiser Permanente Ventures in Pleasanton focused on Health Care and Mobile. Christopher M. Grant is based out of Pleasanton, California and is the Executive Vice President and Chief Operating Officer of Kaiser Permanente Ventures. Christopher previously worked at Rockwell International as a Business Development and Financial Manageme. Christopher M. Grant attended the University of California, Santa Barbara.

## Contacts

5 contacts available for Christopher Grant: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/chris-grant?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Mobile | 1 | 20% |
| Medical | 1 | 20% |
| Hospital | 1 | 20% |
| Automotive | 1 | 20% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 20% |
| Series D | 1 | 20% |
| Series E | 1 | 20% |
| Funding Round | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Torax Medical | Torax Medical, Inc., a clinical stage medical device company, develops an implantable device for the treatment of gastroesophageal reflux disease. It provides treatments for digestive diseases, including acid reflux. The company was founded in 2002 and is based in Shoreview, Minnesota. | $25M | Series E | Jul 26, 2016 | http://www.toraxmedical.com |
| Xanitos | Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patent pending XRO system for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing,profits will follow.Graeme Crothall, founder and CEO, has 40 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads.The results are evident; at the hospitals it serves, Xanitos has improved the cleaning quality, increased HCAHPS scores, reduced the risk of HAIs, lowered bed turn around time, and significantly reduced costs. | $7M |  | Sep 20, 2013 | http://xanitos.com |
| Torax Medical | Torax Medical, Inc., a clinical stage medical device company, develops an implantable device for the treatment of gastroesophageal reflux disease. It provides treatments for digestive diseases, including acid reflux. The company was founded in 2002 and is based in Shoreview, Minnesota. | $30M | Series D | Sep 19, 2012 | http://www.toraxmedical.com |
| Xanitos | Xanitos is a management company that provides hospital housekeeping, patient transport, and central laundries services. It is differentiated by its patent pending XRO system for cleaning patient rooms, its outstanding operations management team, and by being a private company whose priority is giving top quality service, believing that by so doing,profits will follow.Graeme Crothall, founder and CEO, has 40 years’ experience in hospital housekeeping and during that time he has founded and led four successful companies in the industry whose revenues today exceed $2.5 billion. In 2008 Graeme founded Xanitos by acquiring two small companies, one of which owned the XRO patient room cleaning system, and continuing his track-record of providing top quality service, attracting and holding excellent operations management, and always growing the companies he leads.The results are evident; at the hospitals it serves, Xanitos has improved the cleaning quality, increased HCAHPS scores, reduced the risk of HAIs, lowered bed turn around time, and significantly reduced costs. | $9M |  | Nov 14, 2011 | http://xanitos.com |
| Proteus Digital Health | Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and healthsystems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved. | $6.3M | Series B | Jun 23, 2004 | http://www.proteus.com |

5 of 5 investments shown.

## Co-investors
- [Accuitive Medical Ventures](https://shizune.co/investors/profile/accuitive-medical-ventures) — VC Fund, 2 deals together
- [Mayo Clinic Ventures](https://shizune.co/investors/profile/mayo-clinic-ventures) — VC Fund, 2 deals together
- [Sanderling Ventures](https://shizune.co/investors/profile/sanderling-ventures) — VC Fund, 2 deals together
- [Adams Street Partners](https://shizune.co/investors/profile/adams-street-partners) — VC Fund, 1 deal together
- [Asset Management Company](https://shizune.co/investors/profile/asset-managementcompany) — VC Fund, 1 deal together
- [Asset Management Ventures (AMV)](https://shizune.co/investors/profile/asset-management-ventures) — VC Fund, 1 deal together

## About Kaiser Permanente Ventures

VC Fund · Oakland, United States

Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.

5 contacts available at Kaiser Permanente Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Amy Belt Raimundo | Managing Director | https://shizune.co/investors/profile/amy-belt |
| Bryan Sivak | Managing Director | https://shizune.co/investors/profile/bryan-sivak |
| Christopher Grant | Executive Vice President and Chief Operating Officer | https://shizune.co/investors/profile/chris-grant |
| Jodie Ha | Associate | https://shizune.co/investors/profile/jodie-ha |
| Liz Rockett | Managing Director | https://shizune.co/investors/profile/liz-rockett |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Christopher Grant invest in?

Christopher Grant invests primarily in Health Care, Mobile and Medical startups, most often at Series B and Series D stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Christopher Grant?

Public channels for Christopher Grant include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Christopher Grant last invest?

The most recent investment recorded for Christopher Grant closed in Jul 2016. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co